Advertisement
Screener

CABALETTA BIO, INC. (CABA) ROA

CABALETTA BIO, INC. (CABA) ROA

  • 2026-06-30: ROA -70.63%.
  • 2026-03-31: ROA -118.42%.
  • 2025-12-31: ROA -101.68%.
  • 2025-09-30: ROA -83.54%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-70.63%
2026-03-31-118.42%
2025-12-31-101.68%
2025-09-30-83.54%
2025-06-30-64.27%
2025-03-31-76.76%
2024-12-31-62.61%
2024-09-30-50.96%
2024-06-30-41.39%
2024-03-31-31.97%
2023-12-31-26.68%
2023-09-30-36.06%
2023-06-30-31.12%
2023-03-31-54.02%
2022-12-31-45.29%
2022-09-30-55.82%
2022-06-30-50.29%
2022-03-31-43.58%
2021-12-31-36.64%
2021-09-30-34.01%
2021-06-30-36.05%
2021-03-31-33.14%
2020-12-31-29.06%
2020-09-30-24.17%
2020-06-30-20.09%
2020-03-31-15.48%
2019-12-31-11.98%
2019-09-30-17.94%

Annual ROA

DateROA
2025-12-31-101.68%
2024-12-31-62.61%
2023-12-31-26.68%
2022-12-31-45.29%
2021-12-31-36.64%
2020-12-31-29.06%
2019-12-31-11.98%
2018-12-31-35.71%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
AGENUS INC (AGEN)United States$0.383B1.41
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02